What is Imalux?
Imalux, originally incorporated as Optical Coherence Technologies, Inc. in 1996 and later renamed, is a Cleveland, Ohio-based company specializing in optical coherence tomography (OCT) imaging systems. The company's journey began with initial seed funding for investigational studies and patent filings, culminating in the transfer of technology ownership from the Russian Academy of Sciences. Imalux has successfully developed and received FDA clearance, ISO, and CE Mark certification for its Niris® Imaging System, a testament to its technological advancements and market readiness. The company's focus on refining its business plan and technology has been supported by strategic capital injections throughout its history.
How much funding has Imalux raised?
Imalux has raised a total of $17.7M across 5 funding rounds:
Unspecified
$540K
Series A
$3.5M
Series B
$4.8M
Series C
$5.3M
Series D
$3.5M
Unspecified (2001): $540K, investors not publicly disclosed
Series A (2003): $3.5M, investors not publicly disclosed
Series B (2005): $4.8M, investors not publicly disclosed
Series C (2007): $5.4M featuring Early Stage Partners, Symark LLC, ElectroSonics Medical, and Reservoir Venture Partners
Series D (2012): $3.5M, investors not publicly disclosed
Key Investors in Imalux
Early Stage Partners
Early Stage Partners is a venture capital firm established in 2001, focused on supporting technology companies in the Midwest. The firm provides capital, advice, and connections to promising early-stage companies, aiming to foster success for entrepreneurs and investors alike.
Reservoir Venture Partners
Reservoir Venture Partners is a company that operates in the Venture Capital & Private Equity industry. It employs 10to19 people and has 1Mto5M of revenue.
Symark LLC
Symark LLC is an entity associated with Bill Sanford, Founder and Chairman, who is also the retired Chairman and CEO of STERIS Corporation, indicating a focus on medical device industry investments.
What's next for Imalux?
With a history of significant enterprise-level funding and a recent major strategic investment, Imalux is positioned for continued expansion and technological refinement. The company's trajectory, marked by multiple financing rounds and an NIH Fast-Track Award, indicates a strong commitment to clinical validation and market penetration. Future endeavors will likely focus on leveraging its OCT-based Niris® Imaging System to address critical needs in medical diagnostics and imaging, potentially exploring new applications and partnerships to further solidify its market presence.
See full Imalux company page
